Search Results

• • 15 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Factors associated with complications of Clostridium difficile infection in a multicenter prospective cohort

  Authors:Claire Nour Abou Chakra, Allison McGeer, Annie-Claude Labbe, Andrew E. Simor, Wayne L. Gold, Matthew P. Muller, et al.From:Clinical Infectious Diseases (Vol. 61, Issue 12) Peer-Reviewed

  Dec. 15, 2015 Report

   Citation Only

• Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada

  Authors:Philipp P. Kohler, Roberto G. Melano, Samir N. Patel, Shumona Shafinaz, Amna Faheem, Brenda L. Coleman, et al.From:Emerging Infectious Diseases (Vol. 24, Issue 9) Peer-Reviewed

  Sept. 20184,787 words Article 1470LWe analyzed population-based surveillance data from the Toronto Invasive Bacterial Diseases Network to describe carbapenemase-producing Enterobacteriaceae (CPE) infections during 2007-2015 in south-central Ontario,...

• One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome

  Authors:Catherine M. Tansey, Marie Louie, Mark Loeb, Wayne L. Gold, Matthew P. Muller, JoAnne de Jager, et al.From:Archives of Internal Medicine (Vol. 167, Issue 12) Peer-Reviewed

  June 25, 2007 Article

   Citation Only

• Endogenous Klebsiella endophthalmitis in a Vietnamese immigrant

  Authors:Malika Sharma, David R. Chow, and Matthew P. MullerFrom:CMAJ: Canadian Medical Association Journal (Vol. 181, Issue 3) Peer-Reviewed

  Oct. 13, 20091,749 words Case study 1650LA previously healthy 54-year-old carpenter presented with a 13-day history of redness, tearing and pain in his left eye, which was associated with a progressive reduction in visual acuity. He had no fever or other...

• The Impact of Infection on Population Health: Results of the Ontario Burden of Infectious Diseases Study

  Authors:Jeffrey C. Kwong, Sujitha Ratnasingham, Michael A. Campitelli, Nick Daneman, Shelley L. Deeks, Douglas G. Manuel, et al.From:PLoS ONE (Vol. 7, Issue 9) Peer-Reviewed

  Sept. 4, 20126,431 words Report 1660LBackground Evidence-based priority setting is increasingly important for rationally distributing scarce health resources and for guiding future health research. We sought to quantify the contribution of a wide range...

• Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?

  Authors:Matthew P. Muller, George Tomlinson, Thomas J. Marrie, Patrick Tang, Allison McGeer, Donald E. Low, et al.From:Clinical Infectious Diseases (Vol. 40, Issue 8) Peer-Reviewed

  Apr. 15, 2005 Article

   Citation Only

• Severe acute respiratory syndrome

  Authors:Michael D. Christian, Susan M. Poutanen, Mona R. Loutfy, Matthew P. Muller, and Donald E. LowFrom:Clinical Infectious Diseases (Vol. 38, Issue 10) Peer-Reviewed

  May 15, 2004 Article

   Citation Only

• Hospital-associated transmission of Brucella melitensis outside the laboratory

  Authors:Christopher F. Lowe, Adrienne J. Showier, Suzette Perera, Susan McIntyre, Roohi Qureshi, Samir N. Patel, et al.From:Emerging Infectious Diseases (Vol. 21, Issue 1) Peer-Reviewed

  Jan. 20151,922 words Report 1390LBrucella melitensis was identified in an aspirate obtained from a patient's hip joint during a procedure at a hospital in Canada. We conducted an investigation into possible exposures among hospital workers; 1 worker...

• Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillance

  Authors:Stefan P. Kuster, Wallis Rudnick, Altynay Shigayeva, Karen Green, Mahin Baqi, Wayne L. Gold, et al.From:Clinical Infectious Diseases (Vol. 59, Issue 7) Peer-Reviewed

  Oct. 1, 2014 Report

   Citation Only

• Development of a triage protocol for critical care during an influenza pandemic

  Authors:Michael D. Christian, Laura Hawryluck, Randy S. Wax, Tim Cook, Neil M. Lazar, Margaret S. Herridge, et al.From:CMAJ: Canadian Medical Association Journal (Vol. 175, Issue 11) Peer-Reviewed

  Nov. 21, 20064,056 words Clinical report 1840LABSTRACT Background: The recent outbreaks of avian influenza (H5N1) have placed a renewed emphasis on preparing for an influenza pandemic in humans. Of particular concern in this planning is the allocation of...

• Clinical and epidemiologic features of group A streptococcal pneumonia in Ontario, Canada

  Authors:Matthew P. Muller, Donald E. Low, Karen A. Green, Andrew E. Simor, Mark Loeb, Daniel Gregson, et al.From:Archives of Internal Medicine (Vol. 163, Issue 4) Peer-Reviewed

  Feb. 24, 2003 Article

   Citation Only

• Public reporting of hospital hand hygiene compliance helpful or harmful?

  Authors:Allan S. Detsky and Matthew P. MullerFrom:JAMA, The Journal of the American Medical Association (Vol. 304, Issue 10) Peer-Reviewed

  Sept. 8, 201037 words Article

   Citation Only

• Evaluation of Pneumonia Severity and Acute Physiology Scores to Predict ICU Admission and Mortality in Patients Hospitalized for Influenza

  Authors:Matthew P. Muller, Allison J. McGeer, Kazi Hassan, John Marshall, and Michael ChristianFrom:PLoS ONE (Vol. 5, Issue 3) Peer-Reviewed

  Mar. 5, 20104,886 words Article 1500LBackground The demand for inpatient medical services increases during influenza season. A scoring system capable of identifying influenza patients at low risk death or ICU admission could help clinicians make...

• Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings

  Authors:Benjamin J. Cowling, Matthew P. Muller, Irene O.L. Wong, Lai-Ming Ho, Su-Vui Lo, Thomas Tsang, et al.From:Archives of Internal Medicine (Vol. 166, Issue 14) Peer-Reviewed

  July 24, 2006 Article

   Citation Only

• Clinical trials and novel pathogens: lessons learned from SAR-S

  Authors:Matthew P. Muller, Allison McGeer, Sharon E. Straus, Laura Hawryluck, and Wayne L. GoldFrom:Emerging Infectious Diseases (Vol. 10, Issue 3) Peer-Reviewed

  Mar. 20044,229 words Article During the recent global outbreak of severe acute respiratory syndrome (SARS), thousands of patients received treatments such as ribavirin and corticosteroids. Despite this, no controlled clinical trials assessing the...